154 related articles for article (PubMed ID: 1542261)
1. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
Haffner SM; Kushwaha RS; Hazzard WR
Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
[TBL] [Abstract][Full Text] [Related]
2. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
[TBL] [Abstract][Full Text] [Related]
3. A mouse model with features of familial combined hyperlipidemia.
Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL; Breslow JL; Tall AR
Science; 1997 Jan; 275(5298):391-4. PubMed ID: 8994037
[TBL] [Abstract][Full Text] [Related]
4. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
[TBL] [Abstract][Full Text] [Related]
6. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
Kissebah AH; Alfarsi S; Adams PW
Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
[TBL] [Abstract][Full Text] [Related]
7. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
[TBL] [Abstract][Full Text] [Related]
8. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
Cortner JA; Coates PM; Liacouras CA; Jarvik GP
J Pediatr; 1993 Aug; 123(2):177-84. PubMed ID: 8345411
[TBL] [Abstract][Full Text] [Related]
9. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
Kissebah AH; Alfarsi S; Evans DJ
Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
[TBL] [Abstract][Full Text] [Related]
10. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
[TBL] [Abstract][Full Text] [Related]
11. Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging.
Kuromori Y; Okada T; Iwata F; Hara M; Noto N; Harada K
J Atheroscler Thromb; 2002; 9(6):314-20. PubMed ID: 12560593
[TBL] [Abstract][Full Text] [Related]
12. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
Austin MA; Brunzell JD; Fitch WL; Krauss RM
Arteriosclerosis; 1990; 10(4):520-30. PubMed ID: 2369363
[TBL] [Abstract][Full Text] [Related]
13. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.
Keulen ET; Kruijshoop M; Schaper NC; Hoeks AP; de Bruin TW
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):283-8. PubMed ID: 11834529
[TBL] [Abstract][Full Text] [Related]
14. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
[TBL] [Abstract][Full Text] [Related]
15. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia.
Kwiterovich PO; White S; Forte T; Bachorik PS; Smith H; Sniderman A
Arteriosclerosis; 1987; 7(3):211-25. PubMed ID: 3593067
[TBL] [Abstract][Full Text] [Related]
16. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
Venkatesan S; Cullen P; Pacy P; Halliday D; Scott J
Arterioscler Thromb; 1993 Jul; 13(7):1110-8. PubMed ID: 8318511
[TBL] [Abstract][Full Text] [Related]
17. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
Schonfeld G; Aguilar-Salina C; Elias N
Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813
[TBL] [Abstract][Full Text] [Related]
18. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
Cruz-Bautista I; Mehta R; Cabiedes J; García-Ulloa C; Guillen-Pineda LE; Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
Clin Chim Acta; 2015 Jan; 438():160-5. PubMed ID: 25172037
[TBL] [Abstract][Full Text] [Related]
19. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
